Defunct Company
Total Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
9,581
NCT02438462
Soluble Fibrin for Diagnosing Pulmonary Embolism
Phase: N/A
Role: Lead Sponsor
Start: Jun 30, 2015
Completion: Jun 30, 2017
NCT02552381
Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH
Start: Aug 31, 2015
Completion: Dec 20, 2019
NCT02523937
Evaluation of Soluble Fibrin in Thrombosis Exclusion
Start: Sep 30, 2015
Completion: Jul 31, 2018
NCT02856789
Determination of Fibrin Activity in Plasma on STA-R® Prototype
Start: Aug 31, 2016
Completion: Mar 31, 2020
NCT06480994
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
Start: Jun 21, 2022
Completion: Feb 28, 2027
NCT06192017
Development of a Molecular Diagnostic Tool for Endometrial Cancer.
Start: Oct 18, 2023
Completion: Jul 31, 2025
NCT07148154
Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations
Start: Jun 24, 2024
Completion: Sep 30, 2026
NCT07097337
Point of Care Fibrinogen Measurement in Trauma Patients in the Emergency Department
Role: Collaborator
Start: Sep 1, 2025
Completion: Jan 1, 2027